Chemoinformaics analysis of CALYCOSIN-7-O-BETA-D-GLUCOSIDE
| Molecular Weight | 446.408 | nRot | 5 |
| Heavy Atom Molecular Weight | 424.232 | nRig | 24 |
| Exact Molecular Weight | 446.121 | nRing | 4 |
| Solubility: LogS | -4.041 | nHRing | 2 |
| Solubility: LogP | 0.156 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 59.4294 |
| nHD | 5 | BPOL | 29.8826 |
| QED | 0.37 |
| Synth | 3.748 |
| Natural Product Likeliness | 1.536 |
| NR-PPAR-gamma | 0.173 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.473 |
| HIA | 0.749 |
| CACO-2 | -5.856 |
| MDCK | 0.0000546 |
| BBB | 0.411 |
| PPB | 0.810164 |
| VDSS | 0.726 |
| FU | 0.124386 |
| CYP1A2-inh | 0.061 |
| CYP1A2-sub | 0.105 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.082 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.446 |
| CYP2d6-inh | 0.12 |
| CYP2d6-sub | 0.615 |
| CYP3a4-inh | 0.081 |
| CYP3a4-sub | 0.056 |
| CL | 3.693 |
| T12 | 0.393 |
| hERG | 0.053 |
| Ames | 0.398 |
| ROA | 0.084 |
| SkinSen | 0.062 |
| Carcinogencity | 0.86 |
| EI | 0.011 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.8 |
| Antiviral | Yes |
| Prediction | 0.866707 |